← Open Payments lookup

NICOLE BRAMWELL: Open Payments

NPI 1962084483 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,311 in 71 payments from 9 companies in 2025. Trend: 2023 $989 · 2024 $1,195 · 2025 $1,311

Food & beverage: $1,311
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$270
E.R. Squibb & Sons, L.L.C.17$248
Alkermes, Inc.13$236
Otsuka America Pharmaceutical, Inc.7$148
Vanda Pharmaceuticals Inc.7$120
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$90
ABBVIE INC.4$85
Janssen Pharmaceuticals, Inc2$63
Teva Pharmaceuticals USA, Inc.3$50

Products named: INGREZZA, COBENFY, ARISTADA, REXULTI, FANAPT, CAPLYTA, VRAYLAR, INVEGA SUSTENNA.

Industry payments across FL — which companies pay providers there.